Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine
Kunal Ajmera
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 pandemic has taken away the lives of many people (>4 million per WHO) around the world as of July 2021. With the advancement of the vaccine against COVID-19, in less than a year since the start of the pandemic, the infection rate has come under control in certain regions but is still rising in many more. However, with time, we are also learning a lot more about the adverse events related to the vaccine. This report documents the first fatal case of rhabdomyolysis potentially associated with the COVID-19 vaccine and supports the possibility that autoimmunity is a major risk factor for covid vaccine-related rhabdomyolysis.
Topics & Concepts
RhabdomyolysisPandemicCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusVirologyAdverse effectImmunologyIntensive care medicineInfectious disease (medical specialty)Internal medicineOutbreakDiseaseMuscle and Compartmental DisordersInflammatory Myopathies and DermatomyositisBody Contouring and Surgery